Regeneron Pharmaceuticals (REGN) Profit After Tax Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.08% |
| Dec 31, 2025 | -7.97% |
| Sep 30, 2025 | 8.91% |
| Jun 30, 2025 | -2.84% |
| Mar 31, 2025 | 12.01% |
| Dec 31, 2024 | -20.86% |
| Sep 30, 2024 | 33.02% |
| Jun 30, 2024 | 47.90% |
| Mar 31, 2024 | -11.71% |
| Dec 31, 2023 | -3.13% |
| Sep 30, 2023 | -23.40% |
| Jun 30, 2023 | 13.65% |
| Mar 31, 2023 | -15.99% |
| Dec 31, 2022 | -46.29% |
| Sep 30, 2022 | -19.39% |
| Jun 30, 2022 | -72.50% |
| Mar 31, 2022 | -12.71% |
| Dec 31, 2021 | 93.96% |
| Sep 30, 2021 | 93.82% |
| Jun 30, 2021 | 245.36% |
| Mar 31, 2021 | 78.55% |
| Dec 31, 2020 | 45.10% |
| Sep 30, 2020 | 25.76% |
| Jun 30, 2020 | 364.68% |
| Mar 31, 2020 | 35.46% |
| Dec 31, 2019 | -3.46% |
| Sep 30, 2019 | 12.59% |
| Jun 30, 2019 | -64.98% |
| Mar 31, 2019 | -3.54% |
| Dec 31, 2018 | 372.85% |
| Sep 30, 2018 | 53.15% |
| Jun 30, 2018 | 42.22% |
| Mar 31, 2018 | 92.04% |
| Dec 31, 2017 | -31.45% |
| Sep 30, 2017 | 46.64% |
| Jun 30, 2017 | 97.59% |
| Mar 31, 2017 | 37.22% |
| Dec 31, 2016 | 63.31% |
| Sep 30, 2016 | 25.86% |
| Jun 30, 2016 | 0.81% |
| Mar 31, 2016 | 138.60% |
| Dec 31, 2015 | 72.03% |
| Sep 30, 2015 | 152.35% |
| Jun 30, 2015 | 102.01% |
| Mar 31, 2015 | 11.30% |
| Dec 31, 2014 | -6.93% |
| Sep 30, 2014 | -41.00% |
| Jun 30, 2014 | 10.27% |
| Mar 31, 2014 | -30.92% |
| Dec 31, 2013 | -79.42% |
| Sep 30, 2013 | -26.20% |
| Jun 30, 2013 | 13.86% |
| Mar 31, 2013 | 748.63% |
| Dec 31, 2012 | 980.20% |
| Sep 30, 2012 | 407.01% |
| Jun 30, 2012 | 222.78% |
| Mar 31, 2012 | 126.82% |
| Dec 31, 2011 | -266.12% |
| Sep 30, 2011 | -84.10% |
| Jun 30, 2011 | -145.37% |
| Mar 31, 2011 | -42.35% |
| Dec 31, 2010 | 60.00% |
| Sep 30, 2010 | -3,237.44% |
| Jun 30, 2010 | -70.53% |